Earnings Call · Q2 FY2022·2022-08-11

Q2 22EPS -28.50%·Rev n/aQ1 22EPS -62.00%·Rev n/aQ4 21EPS -100.00%*·Rev n/aQ3 21EPS -38.00%·Rev n/a⚠ consensus missing

Insight Molecular Diagnostics Inc. IMDX

Caroline Corner — Investor Relations

Ronnie Andrews — Chief Executive Officer

Anish John — Chief Financial Officer

+2.8%1d on move date+2.8% vs SPY3d+2.0%5d−8.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMDX calls or request research access.

More IMDX calls Browse calls Request research access